The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: Leukocyte- and context-specific effects

International Immunopharmacology

Volumn 18, Issue 2, 2014, Pages 290-297

  Deronic, Adnan ^a   Helmersson, Sofia ^a   Leanderson, Tomas ^a   Ivars, Fredrik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Immunomodulation; Inflammation; Monocyte; Omentum; Peritoneum; Quinoline 3 carboxamide

Indexed keywords

ABR 215757; CD11B ANTIGEN; PAQUINIMOD; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; EOSINOPHIL; GREATER OMENTUM; IMMUNIZATION; INFLAMMATION; LEUKOCYTE FUNCTION AND CHARACTERISTICS; LEUKOCYTE RECRUITMENT; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM; PERITONEUM LAVAGE; PRIORITY JOURNAL; STEADY STATE; TISSUE INJURY;

IMMUNOMODULATION; INFLAMMATION; MONOCYTE; OMENTUM; PERITONEUM; QUINOLINE-3-CARBOXAMIDE;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIGENS, CD11B; CELL LINE, TUMOR; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; MICE; MICE, INBRED C57BL; PERITONITIS; QUINOLINES;

EID: 84891766095     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.12.008     Document Type: Article

References (62)

1. L.C. Davies, M. Rosas, P.J. Smith, D.J. Fraser, S.A. Jones, and P.R. Taylor A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation Eur J Immunol 41 2011 2155 2164
2. E.E. Ghosn, A.A. Cassado, G.R. Govoni, T. Fukuhara, Y. Yang, and D.M. Monack et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets Proc Natl Acad Sci U S A 107 2010 2568 2573
3. J.F. Cailhier, M. Partolina, S. Vuthoori, S. Wu, K. Ko, and S. Watson et al. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation J Immunol 174 2005 2336 2342
4. W.J. Martin, M. Walton, and J. Harper Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout Arthritis Rheum 60 2009 281 289
5. S. Yung, and T.M. Chan Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells Mediators Inflamm 2012 2012 484167
6. N.S. Doherty, R.J. Griffiths, J.P. Hakkinen, D.N. Scampoli, and A.J. Milici Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis Inflamm Res 44 1995 169 177
7. K. Fukatsu, H. Saito, I. Han, H. Yasuhara, M.T. Lin, and T. Inoue et al. The greater omentum is the primary site of neutrophil exudation in peritonitis J Am Coll Surg 183 1996 450 456
8. C. Auffray, D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, and S. Kayal et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior Science (New York, NY) 317 2007 666 670
9. S.J. Jenkins, D. Ruckerl, P.C. Cook, L.H. Jones, F.D. Finkelman, and N. van Rooijen et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation Science (New York, NY) 332 2011 1284 1288
10. H. Kono, D. Karmarkar, Y. Iwakura, and K.L. Rock Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death J Immunol 184 2010 4470 4478
11. T. Eigenbrod, J.H. Park, J. Harder, Y. Iwakura, and G. Nunez Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells J Immunol 181 2008 8194 8198
12. M.T. Lotze, H.J. Zeh, A. Rubartelli, L.J. Sparvero, A.A. Amoscato, and N.R. Washburn et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity Immunol Rev 220 2007 60 81
13. P. Matzinger Tolerance, danger, and the extended family Annu Rev Immunol 12 1994 991 1045
14. T. Chavakis, A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, and T. Linn et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment J Exp Med 198 2003 1507 1515
15. D. Frommhold, A. Kamphues, I. Hepper, M. Pruenster, I.K. Lukic, and I. Socher et al. RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo Blood 116 2010 841 849
16. E. Harja, D.X. Bu, B.I. Hudson, J.S. Chang, X. Shen, and K. Hallam et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE -/- mice J Clin Invest 118 2008 183 194
17. B. Liliensiek, M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, and S. Hofer et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 2004 1641 1650
18. A.M. Schmidt, O. Hori, J.X. Chen, J.F. Li, J. Crandall, and J. Zhang et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 96 1995 1395 1403
19. C.J. Chen, H. Kono, D. Golenbock, G. Reed, S. Akira, and K.L. Rock Identification of a key pathway required for the sterile inflammatory response triggered by dying cells Nat Med 13 2007 851 856
20. H. Kono, C.J. Chen, F. Ontiveros, and K.L. Rock Uric acid promotes an acute inflammatory response to sterile cell death in mice J Clin Invest 120 2010 1939 1949
21. S.S. Iyer, W.P. Pulskens, J.J. Sadler, L.M. Butter, G.J. Teske, and T.K. Ulland et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome Proc Natl Acad Sci U S A 106 2009 20388 20393
22. H. Li, A. Ambade, and F. Re Cutting edge: necrosis activates the NLRP3 inflammasome J Immunol 183 2009 1528 1532
23. F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241
24. V. Hornung, F. Bauernfeind, A. Halle, E.O. Samstad, H. Kono, and K.L. Rock et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization Nat Immunol 9 2008 847 856
25. M. Kool, T. Soullie, M. van Nimwegen, M.A. Willart, F. Muskens, and S. Jung et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells J Exp Med 205 2008 869 882
26. S.C. Eisenbarth, O.R. Colegio, W. O'Connor, F.S. Sutterwala, and R.A. Flavell Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants Nature 453 2008 1122 1126
27. M. Kool, M.A. Willart, M. van Nimwegen, I. Bergen, P. Pouliot, and J.C. Virchow et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma Immunity 34 2011 527 540
28. E. Kuroda, K.J. Ishii, S. Uematsu, K. Ohata, C. Coban, and S. Akira et al. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms Immunity 34 2011 514 526
29. J. Bjork, and S. Kleinau Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice Agents Actions 27 1989 319 321
30. C. Brunmark, A. Runstrom, L. Ohlsson, B. Sparre, T. Brodin, and M. Astrom et al. The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis J Neuroimmunol 130 2002 163 172
31. D.J. Gross, L. Weiss, I. Reibstein, G. Hedlund, E. Dahlen, and M.J. Rapoport et al. The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus Int Immunopharmacol 1 2001 1131 1139
32. A. Runstrom, T. Leanderson, L. Ohlsson, and B. Axelsson Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice J Neuroimmunol 173 2006 69 78
33. C. Wegner, C. Stadelmann, R. Pfortner, E. Raymond, S. Feigelson, and R. Alon et al. Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis J Neuroimmunol 227 2010 133 143
34. G. Comi, O. Abramsky, T. Arbizu, A. Boyko, R. Gold, and E. Havrdova et al. Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study Multiple sclerosis (Houndmills, Basingstoke, England) 16 2010 1360 1366
35. G. Comi, D. Jeffery, L. Kappos, X. Montalban, A. Boyko, and M.A. Rocca et al. Placebo-controlled trial of oral laquinimod for multiple sclerosis N Engl J Med 366 2012 1000 1009
36. G. Comi, A. Pulizzi, M. Rovaris, O. Abramsky, T. Arbizu, and A. Boiko et al. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study Lancet 371 2008 2085 2092
37. C. Polman, F. Barkhof, M. Sandberg-Wollheim, A. Linde, O. Nordle, and T. Nederman Treatment with laquinimod reduces development of active MRI lesions in relapsing MS Neurology 64 2005 987 991
38. O. Bratt, M. Haggman, G. Ahlgren, O. Nordle, A. Bjork, and J.E. Damber Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer Br J Cancer 101 2009 1233 1240
39. R. Pili, M. Haggman, W.M. Stadler, J.R. Gingrich, V.J. Assikis, and A. Bjork et al. Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer J Clin Oncol 29 2011 4022 4028
40. P. Bjork, A. Bjork, T. Vogl, M. Stenstrom, D. Liberg, and A. Olsson et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides PLoS Biol 7 2009 e97
41. S. Helmersson, A. Sundstedt, A. Deronic, T. Leanderson, and F. Ivars Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells Am J Pathol 182 2013 1671 1680
42. A.A. Bengtsson, G. Sturfelt, C. Lood, L. Ronnblom, R.F. van Vollenhoven, and B. Axelsson et al. Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus Arthritis Rheum 64 2012 1579 1588
43. S. Helmersson, M. Stenstrom, T. Leanderson, and F. Ivars Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1 + cells Int Immunopharmacol 11 2011 1045 1051
44. M.W. Moore, F.R. Carbone, and M.J. Bevan Introduction of soluble protein into the class I pathway of antigen processing and presentation Cell 54 1988 777 785
45. D.A. Carlow, M.R. Gold, and H.J. Ziltener Lymphocytes in the peritoneum home to the omentum and are activated by resident dendritic cells J Immunol 183 2009 1155 1165
46. M.W. Barth, J.A. Hendrzak, M.J. Melnicoff, and P.S. Morahan Review of the macrophage disappearance reaction J Leukoc Biol 57 1995 361 367
47. S.A. Ha, M. Tsuji, K. Suzuki, B. Meek, N. Yasuda, and T. Kaisho et al. Regulation of B1 cell migration by signals through Toll-like receptors J Exp Med 203 2006 2541 2550
48. S. Berberich, R. Forster, and O. Pabst The peritoneal micromilieu commits B cells to home to body cavities and the small intestine Blood 109 2007 4627 4634
49. E. Van Vugt, E.A. Van Rijthoven, E.W. Kamperdijk, and R.H. Beelen Omental milky spots in the local immune response in the peritoneal cavity of rats Anat Rec 244 1996 235 245
50. M. Anghelina, P. Krishnan, L. Moldovan, and N.I. Moldovan Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles Am J Pathol 168 2006 529 541
51. C.Z. Behm, B.A. Kaufmann, C. Carr, M. Lankford, J.M. Sanders, and C.E. Rose et al. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis Circulation 117 2008 2902 2911
52. A. Schmeisser, C.D. Garlichs, H. Zhang, S. Eskafi, C. Graffy, and J. Ludwig et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions Cardiovasc Res 49 2001 671 680
53. G.J. Bellingan, P. Xu, H. Cooksley, H. Cauldwell, A. Shock, and S. Bottoms et al. Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation J Exp Med 196 2002 1515 1521
54. C. Cao, D.A. Lawrence, D.K. Strickland, and L. Zhang A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics Blood 106 2005 3234 3241
55. K. Liddiard, M. Rosas, L.C. Davies, S.A. Jones, and P.R. Taylor Macrophage heterogeneity and acute inflammation Eur J Immunol 41 2011 2503 2508
56. C. Ohnmacht, A. Pullner, N. van Rooijen, and D. Voehringer Analysis of eosinophil turnover in vivo reveals their active recruitment to and prolonged survival in the peritoneal cavity J Immunol 179 2007 4766 4774
57. X.W. Zhang, G. Hedlund, P. Borgstrom, K.E. Arfors, and H. Thorlacius Linomide abolishes leukocyte adhesion and extravascular recruitment induced by tumor necrosis factor alpha in vivo J Leukoc Biol 68 2000 621 626
58. A.S. McKee, M.W. Munks, M.K. MacLeod, C.J. Fleenor, N. Van Rooijen, and J.W. Kappler et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity J Immunol 183 2009 4403 4414
59. K.L. Rock, E. Latz, F. Ontiveros, and H. Kono The sterile inflammatory response Annu Rev Immunol 28 2010 321 342
60. C.N. Serhan, and J. Savill Resolution of inflammation: the beginning programs the end Nat Immunol 6 2005 1191 1197
61. S.L. Dalrymple, R.E. Becker, H. Zhou, T.L. DeWeese, and J.T. Isaacs Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts Prostate 72 2012 638 648
62. E. Kallberg, T. Vogl, D. Liberg, A. Olsson, P. Bjork, and P. Wikstrom et al. S100A9 interaction with TLR4 promotes tumor growth PLoS One 7 2012 e34207